Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Science (New York, N.Y.)|April 13, 2023
Judicial interference with mifepristoneMargaret Hamburg, Joshua SharfsteinPublic Health Reports (Washington, D.C. : 1974)|December 14, 2019
Performance and Priorities: A Cross-sectional Study of Local Health Department Approaches to Essential Public Health ServicesMegan Wallace, Joshua Sharfstein, Justin LesslerExpert Opinion on Drug Safety|February 12, 2024
Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety programDaniel A Salmon, Robert T Chen, Steve Black, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2008
Insurance coverage and access to HIV testing and treatment: considerations for individuals at risk for infection and for those with undiagnosed infectionJennifer Kates, Jeffrey LeviThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 20, 2008
Should a reformed system be prepared for public health emergencies, and what does that mean anyway?Rebecca Katz, Jeffrey LeviNAM Perspectives|March 16, 2022
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment SystemBertha K Madras, N Jia Ahmad, Jenny Wen, et al.American Journal of Public Health|August 24, 2018
Behavioral Health, Local Health Department Accreditation, and Public Health 3.0: Leveraging Opportunities for CollaborationTanner Bommersbach, Kylee Borger, Sarah Steverman, et al.Journal of Deaf Studies and Deaf Education|March 17, 2025
Disparate impact of the COVID-19 pandemic on deaf college studentsCarrie Lou Bloom, Jeffrey Levi PalmerJournal of Public Health Management and Practice : JPHMP|February 15, 2007
Financing public health: diminished funding for core needs and state-by-state variation in supportJeffrey Levi, Chrissie Juliano, Maxwell RichardsonJAMA|February 20, 2019
Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl ProductsJeffrey Eric Rollman, James Heyward, Lily Olson, et al.Pageof 2